D&CVD Publications

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management

Ceriello A, Catrinoiu D, Chandramouli C, Cosentino F, Dombrowsky AC, Itzhak B, Lalic NM, Prattichizzo F, Schnell O, Seferović PM, Valensi P, Standl E; on behalf of the D&CVD EASD Study Group
Cardiovasc Diabetol. 2021 Nov 6;20(1):218. doi:10.1186/s12933-021-01408-1

 

Issues for the management of people with diabetes and COVID-19 in ICU

Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; on behalf of the D&CVD EASD Study Group
Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi:10.1186/s12933-020-01089-2

 

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era

Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; on behalf of the D&CVD EASD Study Group
Diabetes Care 2020 Jul;43(7):1427–1432. doi:10.2337/dc20-0941

 

Report from the 5th cardiovascular outcome trial (CVOT) summit

Schnell O, Standl E, Cos X, Heerspink HJL, Itzhak B, Lalic N, Nauck M, Ceriello A
Cardiovasc Diabetol. 2020 Apr 17;19(1):47. doi:10.1186/s12933-020-01022-7

 

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD)EASD Study Group

Schnell O, Standl E, Catrinoiu D, Itzhak B, Lalic N, Lalic K, Rahelic D; Skrha J, Valensi P, Ceriello A
Cardiovasc Diabetol. 2019 Mar 11;18(1):30. doi:10.1186/s12933-019-0822-4.

 

Winner Abstract "International School of Diabetes": SGLT2 inhibitors to target prediabetes in adults: a randomised, double- blind, placebo-controlled, parallel-group, proof-of-concept study

Beccuti G

 

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD)EASD Study Group

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Lalic K, Skrha J, Valensi P, Ceriello A
Cardiovasc Diabetol. 2018 17:30 doi:10.1186/s12933-018-0667-2.

 

Updates on Cardiovascular Outcome Trials in Diabetes

Schnell O, Rydén L, Standl E, Ceriello A and on behalf of the D&CVD EASD Study Group
Cardiovascular Diabetology 2017 16:128 doi:10.1186/s12933-017-0610-y

 

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Skrha J, Valensi P, Rahelic D, Ceriello A
Cardiovasc Diabetol. 2017 18;16:35. doi:10.1186/s12933-017-0508-x.

 

Current perspectives on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A
Cardiovasc Diabetol. 2016 Oct 1;15(1):139.

 

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group.

Schnell O, Standl E, Catrinoiu D, Genovese S, Lalic N, Skra J, Valensi P, Ceriello A
Cardiovasc Diabetol. 2016 Feb 18;15:33. doi:10.1186/s12933-016-0357-x.

 

Type 1 diabetes and cardiovascular disease

Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A
Cardiovascular Diabetology 2013, 12: 156